Desheng Xu
Overview
Explore the profile of Desheng Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1086
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duan W, Zhao W, Xu D
Heliyon
. 2024 Dec;
10(23):e39764.
PMID: 39687152
As an important strategic energy base in China, Inner Mongolia's energy exports are dominated by coal and electricity. Under the background of "double carbon" target, the energy transition of Inner...
2.
Zhang H, Xiong R, Peng S, Xu D, Ke J
Nanomaterials (Basel)
. 2023 May;
13(10).
PMID: 37242016
In this paper, high-activity manganese oxide was prepared from electrolytic manganese anode slime to realize the efficient removal of antibiotics. The effects of sulfuric acid concentration, ethanol dosage, liquid-solid ratio,...
3.
Tang D, Xu D, Luo Z, Ke J, Zhou Y, Li L, et al.
Nanomaterials (Basel)
. 2022 Jul;
12(14).
PMID: 35889679
Developing suitable photocatalysts for the oxygen evolution reaction (OER) is still a challenging issue for efficient water splitting due to the high requirements to create a significant impact on water...
4.
Zhang M, Ke J, Xu D, Zhang X, Liu H, Wang Y, et al.
J Colloid Interface Sci
. 2022 Feb;
615:663-673.
PMID: 35158197
In this work, a novel plasmonic ternary Bi/Bismuth oxycarbonate/Zinc bismuth oxide (Bi-BiOCO-ZnBiO) is synthesized synergistically by a one-step hydrothermal method. The results show that the metallic Bi spheres and ZnBiO...
5.
Xiao M, Roh S, Zhou J, Chien C, Lucey B, Craig M, et al.
Sci Adv
. 2021 Nov;
7(48):eabf6935.
PMID: 34818031
Schizophrenia is a polygenetic disorder whose clinical onset is often associated with behavioral stress. Here, we present a model of disease pathogenesis that builds on our observation that the synaptic...
6.
Lleo A, Carmona-Iragui M, Videla L, Fernandez S, Benejam B, Pegueroles J, et al.
Alzheimers Res Ther
. 2021 Jun;
13(1):119.
PMID: 34183050
Background: There is an urgent need for objective markers of Alzheimer's disease (AD)-related cognitive impairment in people with Down syndrome (DS) to improve diagnosis, monitor disease progression, and assess response...
7.
Zhao X, Liu K, Xu D, Liu Y, Hu C
Materials (Basel)
. 2020 Dec;
13(24).
PMID: 33327580
AZ91D Mg alloy was treated by ultrasonic surface rolling processing (USRP) and subsequent recovery treatment at different temperatures. The dry sliding friction test was performed to investigate the effects of...
8.
Belbin O, Xiao M, Xu D, Carmona-Iragui M, Pegueroles J, Benejam B, et al.
Mol Neurodegener
. 2020 Aug;
15(1):46.
PMID: 32807227
Background: Alzheimer's disease (AD) is the major cause of death in adults with Down syndrome (DS). There is an urgent need for objective markers of AD in the DS population...
9.
van Steenoven I, Koel-Simmelink M, Vergouw L, Tijms B, Piersma S, Pham T, et al.
Mol Neurodegener
. 2020 Jun;
15(1):36.
PMID: 32552841
Background: Diagnosis of dementia with Lewy bodies (DLB) is challenging, largely due to a lack of diagnostic tools. Cerebrospinal fluid (CSF) biomarkers have been proven useful in Alzheimer's disease (AD)...
10.
van der Ende E, Xiao M, Xu D, Poos J, Panman J, Jiskoot L, et al.
J Neurol Neurosurg Psychiatry
. 2020 Apr;
91(6):612-621.
PMID: 32273328
Introduction: Synapse dysfunction is emerging as an early pathological event in frontotemporal dementia (FTD), however biomarkers are lacking. We aimed to investigate the value of cerebrospinal fluid (CSF) neuronal pentraxins...